{"pageContent": "Differentiation status influences the prognosis for localized prostate cancer. In this issue of Cancer Cell, Mak and coworkers describe a signaling pathway involving estrogen receptor beta (ERbeta) that governs whether prostate carcinoma cells maintain an epithelial phenotype or undergo epithelial-mesenchymal transition, suggesting that ERbeta would have prognostic or therapeutic value.", "metaData": {"source": "Mood outcomes of a behavioral treatment for urinary incontinence in prostate cancer survivors\nhttps://pubmed.ncbi.nlm.nih.gov/30903368/"}}